- Home
- GILD vs CB Comparison
GILD vs CB Comparison
Compare GILD & CB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- CB
- Stock Information
- Founded
- GILD 1987
- CB 1985
- Country
- GILD United States
- CB Switzerland
- Employees
- GILD N/A
- CB N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- CB Property-Casualty Insurers
- Sector
- GILD Health Care
- CB Finance
- Exchange
- GILD Nasdaq
- CB Nasdaq
- Market Cap
- GILD 138.2B
- CB 114.8B
- IPO Year
- GILD 1992
- CB 1993
- Fundamental
- Price
- GILD $111.79
- CB $296.67
- Analyst Decision
- GILD Buy
- CB Buy
- Analyst Count
- GILD 27
- CB 16
- Target Price
- GILD $105.32
- CB $301.13
- AVG Volume (30 Days)
- GILD 10.7M
- CB 2.0M
- Earning Date
- GILD 04-24-2025
- CB 04-22-2025
- Dividend Yield
- GILD 2.83%
- CB 1.23%
- EPS Growth
- GILD N/A
- CB 4.13
- EPS
- GILD 0.38
- CB 22.70
- Revenue
- GILD $28,754,000,000.00
- CB $55,882,000,000.00
- Revenue This Year
- GILD $1.77
- CB N/A
- Revenue Next Year
- GILD $3.52
- CB $5.52
- P/E Ratio
- GILD $294.18
- CB $13.06
- Revenue Growth
- GILD 6.04
- CB 12.45
- 52 Week Low
- GILD $62.07
- CB $238.85
- 52 Week High
- GILD $119.96
- CB $302.05
- Technical
- Relative Strength Index (RSI)
- GILD 57.43
- CB 66.44
- Support Level
- GILD $104.70
- CB $288.36
- Resistance Level
- GILD $107.42
- CB $299.33
- Average True Range (ATR)
- GILD 2.48
- CB 5.07
- MACD
- GILD -0.62
- CB 0.10
- Stochastic Oscillator
- GILD 57.74
- CB 91.13
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About CB Chubb Limited
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.